The vaccine should be commercially affordable. \ Philip Doyle
ADVERTISEMENT
Some £3.1m has been awarded by the Wellcome Trust to researchers in the UK working with the Pirbright Institute and MSD to develop a new vaccine for foot and mouth disease (FMD).
Foot and mouth has been found to be on the spread in certain regions such as East Africa, and the vaccine is aimed at being commercially affordable for farmers in impoverished regions.
“While our initial research has provided proof of concept, this funding will allow us to answer the remaining product development challenges and further improve the stability of the vaccine,” Dr Bryan Charleston, leader of the research and director of The Pirbright Institute, said.
ADVERTISEMENT
The new vaccine is derived from non-genetic material and is intended to be easier to produce and store than previously thought possible.
Foot and mouth
Many Irish farmers will remember the outbreak of the disease in 2001, which led to the culling of animals and the postponement of St Patrick’s Day.
Cattle, sheep and pigs are all susceptible to the disease and it is highly infectious. Humans can also contract the disease, though it usually has a milder impact on people than animals.
This content is available to digital subscribers and loyalty code users only. Sign in to your account, use the code or subscribe to get unlimited access.
The reader loyalty code gives you full access to the site from when you enter it until the following Wednesday at 9pm. Find your unique code on the back page of Irish Country Living every week.
CODE ACCEPTED
You have full access to the site until next Wednesday at 9pm.
CODE NOT VALID
Please try again or contact support.
Some £3.1m has been awarded by the Wellcome Trust to researchers in the UK working with the Pirbright Institute and MSD to develop a new vaccine for foot and mouth disease (FMD).
Foot and mouth has been found to be on the spread in certain regions such as East Africa, and the vaccine is aimed at being commercially affordable for farmers in impoverished regions.
“While our initial research has provided proof of concept, this funding will allow us to answer the remaining product development challenges and further improve the stability of the vaccine,” Dr Bryan Charleston, leader of the research and director of The Pirbright Institute, said.
The new vaccine is derived from non-genetic material and is intended to be easier to produce and store than previously thought possible.
Foot and mouth
Many Irish farmers will remember the outbreak of the disease in 2001, which led to the culling of animals and the postponement of St Patrick’s Day.
Cattle, sheep and pigs are all susceptible to the disease and it is highly infectious. Humans can also contract the disease, though it usually has a milder impact on people than animals.
If you would like to speak to a member of our team, please call us on 01-4199525.
Link sent to your email address
We have sent an email to your address. Please click on the link in this email to reset your password. If you can't find it in your inbox, please check your spam folder. If you can't find the email, please call us on 01-4199525.
ENTER YOUR LOYALTY CODE:
The reader loyalty code gives you full access to the site from when you enter it until the following Wednesday at 9pm. Find your unique code on the back page of Irish Country Living every week.
SHARING OPTIONS